A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China
Clinical trial NCT05550142 · UNKNOWN
Trial details
- NCT number
- NCT05550142
- Sponsor
- AIM Vaccine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-16
- Primary completion
- 2022-12-19
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.